Although sumoylation regulates a diverse and growing number of recognized biological processes, the molecular mechanisms by which the covalent attachment of the ubiquitin-like protein SUMO can alter the properties of a target protein remain to be established. To address this question, we have used NMR spectroscopy to characterize the complex of mature SUMO-1 with the C-terminal domain of human RanGAP1. Based on amide chemical shift and 15 N relaxation measurements, we show that the C terminus of SUMO-1 and the loop containing the consensus sumoylation site in RanGAP1 are both conformationally flexible. Furthermore, the overall structure and backbone dynamics of each protein remain unchanged upon the covalent linkage of Lys 524 in RanGAP1 to the C-terminal Gly 97 of SUMO-1. Therefore, SUMO-1 and RanGAP1 behave as "beads-on-astring," connected by a flexible isopeptide tether. Accordingly, the sumoylation-dependent interaction of RanGAP1 with the nucleoporin RanBP2 may arise through the bipartite recognition of both RanGAP1 and SUMO-1 rather than through a new binding surface induced in either individual protein upon their covalent linkage. We hypothesize that this conformational flexibility may be a general feature contributing to the recognition of ubiquitin-like modified proteins by their downstream effector machineries.
nism, allowing rapid and reversible control of a target protein's function by altering its half-life, sub-cellular localization, enzymatic activity, protein-protein interactions, or other properties (see Ref. 1 for a recent review). Ubiquitin itself can direct its targets to a number of different fates, including proteasomal degradation and membrane protein transport (2) . Ubls also control critical cellular functions. For example, NEDD8 activates SCF and related ubiquitin ligases, ISG15/UCRP is induced during in the antiviral interferon response, Apg12p and Apg8p regulate the autophagy pathway, and Hub1p modifies cell polarity factors. The Ubl SUMO regulates a growing number of recognized proteins involved in the cell cycle, DNA repair, the stress response, nuclear transport, transcription, and signal transduction (for recent reviews see Refs. 1 and 3-6).
The first protein shown to be post-translationally modified with SUMO is the RanGTPase-activating protein RanGAP1 (7, 8) . In higher eukaryotes, the cellular localization of RanGAP1 is regulated by sumoylation of its C-terminal domain. During interphase, RanGAP1 is bound to the cytoplasmic side of the nuclear pore complex via a sumoylation-dependent interaction with the IR domain of the large nucleoporin RanBP2/Nup358 (9) . This localization is required to help create and maintain the spatial gradient of the GTP-bound versus GDP-bound forms of Ran across the nuclear envelope necessary to drive nucleocytoplasmic transport (10) . During mitosis, the nuclear envelope breaks down, destroying the Ran-GTP gradient. However, another Ran-GTP gradient is established to help mitotic spindle assembly. Once again, in vertebrates a requisite for the formation of this gradient is the localization of sumoylated RanGAP1 in complex with RanBP2 at the mitotic spindle and with the kinetochores (11) .
After proteolytic cleavage of nascent SUMO to reveal a Cterminal Gly-Gly motif, sumoylation proceeds with the attachment of the mature protein via its C terminus to a cysteine residue in the SAE2 subunit of the heterodimeric E1 activating enzyme SAE1/SAE2. Formation of the thiolester bond is driven energetically by ATP hydrolysis. This reaction is followed by transesterification of SUMO to Cys 93 on UBC9, the E2 conjugating enzyme. Although E3 ligating enzymes, which facilitate sumoylation, have been identified recently, UBC9 is sufficient for transferring SUMO to target proteins such as RanGAP1, at least in vitro (4 -6) . The final product is a covalent isopeptide linkage joining the C-terminal carboxyl of SUMO with the side chain amino group of a lysine in the target protein. There are three paralogs of SUMO present in humans, of which SUMO-2 and SUMO-3, like ubiquitin, can subsequently form polysumoylated chains, whereas SUMO-1 cannot (12) . The residue targeted by SUMO-1 in mouse RanGAP1 is Lys 526 (Lys 524 in the human ortholog) (13) , which lies in a KXE/D sumoylation consensus motif ( represents a large branched hydrophobic residue (Ile, Val, or Leu), and X is any amino acid) (14, 15) . The crystal structure the C-terminal domain of mouse RanGAP1 in complex with the human SUMO E2 conjugating enzyme, UBC9, revealed the molecular determinants for recognition of this motif (16) .
In contrast to a rapidly growing understanding of the enzymatic mechanisms by which Ubls are specifically conjugated to their target proteins (16 -18) , remarkably little is known about the structural consequences of these post-translational modifications. Studies of di-ubiquitin conjugates revealed interactions between the members of a Lys 48 -linked pair, but not between those joined at Lys 63 (19 -21) . The crystal structure of the MoaD:MoaE molybdopterin synthase complex may also shed light on the consequences of Ubl modification. Although MoaD and MoaE are not naturally linked, in this complex the C-terminal glycine of MoaD, which resembles ubiquitin, is isopeptide-bonded to a lysine in MoaE (22) . The structure also revealed extensive non-covalent interactions between MoaD and MoaE, resulting in conformational changes in the interfacial regions of both proteins (23) . These studies raise the key question as to whether Ubl modification of natural targets also involves significant non-covalent Ubl-target interactions leading to conformational changes in either protein or whether the Ubl is simply covalently linked to the target by a flexible tether (6) . For example, it has been hypothesized that sumoylation exposes or creates a new binding surface on RanGAP1 for specific recognition by RanBP2, because neither unmodified SUMO-1 nor RanGAP1 interact with this nucleoporin (13) .
To examine the related concepts regarding the structural and dynamic determinants for the sumoylation of target proteins and the consequences of this post-translational modification, we used NMR spectroscopy to characterize human SUMO-1 and the C-terminal domain of RanGAP1 in their free and covalently linked forms. Based on these studies, we confirm that the target lysine of RanGAP1, as well as the C terminus of mature SUMO-1, lie within mobile regions of the two proteins. Furthermore, we demonstrate that, upon sumoylation, RanGAP1 and SUMO-1 behave as "beads-on-a-string" joined by a flexible isopeptide tether and that their structures and local dynamic features do not change significantly beyond the site of this covalent linkage. These results discount a model of a sumoylation-dependent conformational change in Ran-GAP1 and/or SUMO-1 to mediate RanBP2 binding.
EXPERIMENTAL PROCEDURES
DNA Constructs-Genes encoding residues 1-97 of SUMO-1 (denoted SUMO-1 gg ), residues 420 -587 of RanGAP1 (denoted RanGAP1 c ), and full-length UBC9 were PCR cloned from a human HeLa cell QUICK-Clone cDNA library (Clontech Laboratories) into the pET28a expression vector (Novagen) using NdeI and XhoI restriction enzyme sites. The resulting constructs contained an N-terminal His 6 tag with a thrombin cleavage site such that a Gly-Ser-His extension remained after proteolytic processing. The clone of the yeast E1 activating enzyme (AOS1/UBA1) was generated as described (24) .
Protein Expression and Purification-Proteins were expressed using Escherichia coli BL21( DE3) cells grown in Luria-Bertani media or in M9 media containing 15 NH 4 Cl and/or 13 C 6 -glucose according to standard protocols (25) . Post-induction cells were collected by centrifugation, re-suspended in nickel column binding buffer (500 mM NaCl, 50 mM HEPES, 5 mM imidazole, and 5% glycerol, pH 7.5), lysed with a French Press, and sonicated. The cell debris was pelleted, and the resultant supernatant was filtered through a 0.8-m cellulose acetate membrane (Nalgene) directly onto a nickel-affinity column (HiTrap; Amersham Biosciences). The column was washed with 125 ml of wash buffer (as binding plus 60 mM imidazole), and proteins were eluted with elution buffer (as binding plus 250 mM imidazole). The eluted fractions were pooled and dialyzed overnight into 10 mM NaCl, 50 mM Tris, and 2 mM ␤-mercaptoethanol (pH 7.5) in preparation for sumoylation reactions or into 100 mM KCl, 10 mM potassium phosphate, 5 mM dithiothreitol, and 0.1 mM EDTA at pH 6.0 or 6.5 for NMR spectroscopy. When necessary to remove the His 6 tag, thrombin was included during the dialysis step and subsequently inactivated with p-aminobenzamidine beads (Sigma). Talon metal affinity resin (Clontech) was added in a batch method to remove the cleaved His 6 tag. The final sample concentrations were determined by UV light absorbance using a predicted ⑀ 280 of 29 N-SUMO-1 gg :RanGAP1 c complex, the His 6 tag was cleaved off all the components except RanGAP1 c . Each reaction mixture was diluted into nickel column binding buffer and purified as described above over a nickel-affinity column. After elution, the pooled product was loaded onto a Fractogel® SO 3 Ϫ column (Merck) in 20 mM potassium phosphate and 5 mM ␤-mercaptoethanol (pH 5.5) and eluted over a 120-min period with a 0 -750 mM NaCl gradient in this buffer to further purify the desired complex. The resulting 15 N-RanGAP1 c :SUMO-1 gg and 15 N-SUMO-1 gg :RanGAP1 c were dialyzed into 100 mM KCl, 10 mM potassium phosphate, 5 mM dithiothreitol, and 0.1 mM EDTA at pH 6.0 and 6.5, respectively. Thrombin was included during dialysis to remove the His 6 tag as described above. The final protein complexes were concentrated by ultrafiltration (Millipore) to 0.65 and 0.5 mM, respectively, and D 2 O was added to ϳ10%. Both preparations had an ϳ33% yield. SDS-PAGE and electrospray ionization mass spectroscopy were used to confirm the mass of the complexes. A small amount of unmodified RanGAP1 c and SUMO-1 gg , as well as residual His 6 -tagged complex, was observed in each preparation.
NMR Spectroscopy-Protein samples were in 100 mM KCl, 10 mM potassium phosphate, 5 mM dithiothreitol, 0.1 mM EDTA, and ϳ10% D 2 O at pH 6 or 6.5. Spectra for labeled SUMO-1 gg were recorded at 17°C on a Varian Unity 500 MHz spectrometer. Spectra for labeled RanGAP1 c and UBC9 were recorded at 17 and 30°C on a Varian Inova 600 MHz spectrometer. The reduced temperature was used to limit protein aggregation and/or degradation (26, 27) . N NOE relaxation measurements were recorded as described (30) . Spectral processing, resonance assignments, and relaxation analyses were carried out using NMRPipe (31), SPARKY 3 (32), and Tensor2 (33) . The chemical shift assignments of 
RESULTS

The Target Lysine for Sumoylation of RanGAP1 c by UBC9
Lies in a Flexible Loop-Resonances from the backbone 1 H, 13 C, and 15 N nuclei in the C-terminal domain of human Ran-GAP1 were assigned by established NMR methods ( Fig. 1A and  supplemental Fig. S1 , available in the on-line version of this article). Based on the measured 1 H N , 15 N, 13 C ␣ , 13 C ␤ , and 13 CЈ chemical shifts, the secondary structure of this protein consists of nine ␣-helixes and matches that found in the crystal structure of the closely related mouse protein (82% identical residues) (16) .
The dynamic properties of 15 N-RanGAP1 c were probed using 15 N relaxation experiments, which provide a measure of both the global rotational diffusion of a protein as well as the local mobility of its polypeptide backbone on a residue-specific basis (34) . From the T 1 and T 2 lifetimes of amides within the helical core of RanGAP1 c , an effective correlation time ( c ) of 12.5 Ϯ 0.1 ns was determined for its global tumbling at 17°C. This value is within the range expected for a monomeric protein of 18.7 kDa at this temperature (35 To confirm that the consensus motif in the flexible H6-H7 loop of human RanGAP1 c is the target of UBC9-mediated sumoylation and to verify that a known intermolecular interface for RanGAP1 c can be detected by NMR methods, the interaction between these two proteins in solution was investigated. Specifically, 1 H-15 N HSQC spectra of either 15 N-labeled RanGAP1 c or UBC9 were recorded upon titration with the unlabeled partner (supplemental Fig. S2 , available in the on-line version of this article). The chemical shifts and relaxation properties of a 1 H-15 N group are highly sensitive to its local environment, and, thus, selective perturbations in the HSQC spectrum of a protein provide a means to identify even subtle conformational changes such as those occurring at interaction surfaces. Upon titration, residues in 15 N-RanGAP1 c clustering near helix H6 and the loops between H6-H7 (including Lys 524 ) and H8-H9 showed selective loss of intensity. A similar behavior was observed for residues in 15 N-UBC9 near helix H3, strands S6 and S7, and the catalytic Cys 93 . These regions correspond very well with the intermolecular interface observed in the crystal complex of mouse RanGAP1 c and human UBC9 in which the target lysine from this consensus motif is bound in close proximity to the active site cysteine of the E2 conjugating enzyme (16) . Furthermore, based on the NMR titration data, including the observation of selective conformational exchange broadening, we estimate a dissociation constant (K d ) Ͻ10 M for this protein complex. This K d value is consistent with that of 0.5 M determined for human UBC9 and RanGAP1 c by isothermal titration calorimetry (36) . Thus, NMR methods accurately detect a previously characterized protein-protein interaction involving RanGAP1 c . Parenthetically, this K d is markedly lower than those in the millimolar range reported for peptide models of sumoylation sites from p53 and c-Jun (37) and supports the hypothesis that RanGAP1 c is an efficient substrate for UBC9 because of the significant interaction surfaces between these two proteins. 15 N-RanGAP1 c :SUMO-1 gg were averaged from two measurements. The increased error bars for the complexes versus free proteins reflect the decreased signal-to-noise ratio in the spectra of the larger molecules at lower sample concentrations. Missing data points correspond to prolines or residues with severe spectral overlap. These data are provided in supplemental Table S1 , available in the on-line version of this article.
NOE values (Fig. 2C) . In addition, based on the 15 N T 1 and T 2 relaxation of amides within the structured core of the protein, the effective c for the global tumbling of SUMO-1 gg (11.4 (Fig. 1A) . Given the exquisite sensitivity of amide chemical shifts to local environment, this finding clearly indicates that the overall structure of RanGAP1 c is not significantly perturbed upon covalent modification, nor does a specific interaction occur with SUMO-1 gg . However, detailed inspection of the HSQC spectrum of the complex reveals that signals from residues 519 -534 are relatively weakened, suggestive of localized millisecond time scale conformational exchange broadening due to the tethering of SUMO-1 gg to this loop region. In addition, a strong new peak at 7.85 and 121.0 ppm in 1 (Fig. 3) .
Paralleling the lack of structural perturbations, 1 H-15 N NOE measurements reveal that the fast internal dynamics of the backbone of RanGAP1 c are not significantly changed upon sumoylation (Fig. 2B) . In particular, the H6-H7 loop region containing Lys 524 continues to exhibit reduced NOE values indicative of local conformational mobility (0.72 Ϯ 0.23 for Lys 524 and an average of 0.59 Ϯ 0.16 for residues 520 -535). Moreover, the isopeptide 15 N has a heteronuclear NOE value of 0.23 Ϯ 0.06, demonstrating that the linkage is also very flexible on a sub-nanosecond time scale. Finally, as expected because of an increase in mass, 15 (Fig. 1B) , demonstrating that the structure of SUMO-1 gg is also not perturbed upon covalent linkage to RanGAP1. Chemical shift changes are only observed for Gly 96 and Gly 97 , as is expected for the conversion of the charged C terminus of SUMO-1 gg to a neutral isopeptide. Indeed, the amide chemical shifts of Gly 97 in 15 N-SUMO-1 gg :RanGAP1 c resemble those reported for nascent SUMO-1 with it native C-terminal sequence (His-Ser-ThrVal 101 ) followed by a His 6 tag (27) . Similarly, 15 N relaxation measurements reveal an increase in the effective c for global tumbling of 15 N-SUMO-1 gg to 13.6 Ϯ 0.2 ns at 17°C upon covalent complex formation, yet no overall changes in the pattern of fast internal backbone dynamics are exhibited by this protein (Fig. 2D) . Although the motions of the Thr 95 -Gly 97 , as reflected by 1 H-15 N NOE values, are dampened relative to the free protein because of their direct attachment to RanGAP1 c , these residues remain flexible relative to the well ordered core of SUMO-1 gg .
DISCUSSION
Conformational Flexibility of Sumoylation Sites-As expected from previous studies of nascent 27) , the residues C-terminal to the fifth ␤-strand of mature SUMO-1 gg are conformationally mobile. This flexibility may be critical for the proteolytic activation of SUMO-1 and the de-sumoylation of target proteins (39), as well as for SUMO-1 gg to bind to UBC9 while extending its C terminus to form a thiolester with the distal Cys 93 (16, 29) . Similarly, as was also revealed by 15 relaxation measurements, the sumoylation site in human RanGAP1 c lies within a dynamic region corresponding to the exposed H6-H7 loop observed in the crystal structure of its mouse ortholog complexed with UBC9 (16) . The accessibility and plasticity of this site is likely necessary for the Leu-Lys 524 -Ser-Glu sequence of RanGAP1 c to bind UBC9 in an extended conformation along a shallow surface adjacent to Cys 93 . As hypothesized previously from studies of isolated peptide models of p53 and c-Jun sumoylation sites (37) , this conformational flexibility may be a general feature of the regions in target proteins containing lysines to which SUMO is attached. A survey of characterized sumoylation sites indicates that many indeed fall within the unstructured N-terminal (i.e. histone H4, IB␣, and Sumo-2/3) or C-terminal (p53) tails of proteins or in internal regions linking structured domains (c-Jun and Sp100). However, exceptions may exist as evidenced by reported sumoylation sites within non-loop regions of the well structured PNT domain of Tel (40) and the RING domain of PML (41) . It is possible that E3 SUMO ligases are required to facilitate the attachment of SUMO to such sites in vivo, as the Tel PNT domain is not sumoylated directly by UBC9 in vitro. 
RanGap:SUMO-1 Are Beads-on-a-String Connected via a
Flexible Isopeptide Linker-Although the involvement of sumoylation in regulating several diverse biological processes is well documented, little is understood regarding the molecular mechanisms by which the attachment of SUMO mediates these cellular consequences (6) . In cases such as IB␣ and Mdm2, sumoylation appears to sterically compete with ubiquitinylation of the same target lysine to prevent proteolytic degradation (42, 43) . However SUMO also plays an active role altering the interactions of target protein with other macromolecules. Examples include the sumoylation-dependent assembly of PML nuclear bodies (6), as well as the recruitment of histone deacetylase complexes by sumoylated Elk-1, resulting in transcriptional repression (44) . The activity of an enzyme may also be sumoylation-dependent, as illustrated by the reduction in the DNA binding affinity of thymine-DNA glycosylase upon its covalent linkage to SUMO (45) . As recently reviewed (6), two general, nonexclusive models can be envisioned by which sumoylation could affect the interactions of a target protein with another macromolecule in order to impart a cellular response: (i) upon covalent-linkage the conformation of the target protein and/or SUMO becomes altered, exposing or sequestering a specific recognition surface on one member of the pair; or (ii) as a tethered heterodimer, SUMO and the target protein co-operatively contribute determinants to a new multipartite binding interface.
A description of the structural and dynamic consequences of the covalent linkage of SUMO, ubiquitin, or any other Ubl to target proteins, as is required to distinguish these models, remains remarkably absent in the literature. To date, only two di-ubiquitins and a MoaD:MoaE molybdopterin synthase complex with a non-native isopeptide have been characterized in vitro. The attachment of the C-terminal Gly 76 of one ubiquitin to the Lys 48 of another, as is found in the polyubiquitinylation pathway leading to proteasomal degradation, results in a dynamic equilibrium involving a closed conformation between the two proteins that sequesters a hydrophobic interface (19, 20) . In contrast, attachment through Lys 63 , which acts as a specific signal in several non-degradative processes, leads to no structural perturbations in either member of the ubiquitin pair (21) .
Using NMR spectroscopy we demonstrate that, similar to Lys 63 -linked di-ubiquitin, the RanGAP1 c :SUMO-1 gg complex is connected via a flexible isopeptide linkage with no significant structural interactions between the two proteins. This beadson-a-string behavior (Fig. 1C) 15 N-labeled member of the complex overlaps very closely with that of the corresponding free protein, with the exception of changes in the intensities or chemical shifts of signals from residues immediately adjacent to the isopeptide bond. Thus, beyond these residues, the structure of neither protein is measurably perturbed upon their covalent linkage, nor is a defined interaction surface between the two proteins within the complex detected. Second, the isopeptide bond is very dynamic on a sub-nanosecond time scale as evidenced by a 1 H-15 N NOE value of ϳ0.2. Furthermore, the fast time scale conformational mobility of the flexible loop containing Lys 524 in RanGAP1 c does not markedly change upon sumoylation. The broadening of the resonances from residues 519 to 534 does, however, suggest some slower motions on a chemical shift (i.e. millisecond) time scale for this region to which SUMO-1 gg is now covalently attached. Similarly, the C terminus of SUMO-1 gg remains flexible in complex, although dampened relative to its free state because of hydrodynamic drag from the attached RanGAP1 c . Third, if the two proteins interacted to form a tightly associated pair, one would expect that the effective global c measured for each would be similar and on the order of ϳ21 ns at 17°C. This value, extrapolated from the correlation times determined for free RanGAP1 c (18.7 kDa, 12.5 ns) and SUMO-1 gg (11.4 kDa, 8.6 ns), corresponds to a globular heterodimer with a total molecular mass of 30.1 kDa. However, the c values determined for RanGAP1 c and SUMO-1 gg in complex were 18.1 and 13.6 ns, respectively. The fact that these individual correlation times are both very different from one another and less than that expected for an intimate heterodimer indicates that the two molecules, for the most part, tumble independently within the covalently tethered complex.
It is well established that RanGAP1 requires the attachment of SUMO-1 in order to interact with RanBP2. Accordingly, sumoylation has been hypothesized to expose or create a new binding site on the C-terminal domain of RanGAP1 for RanBP2 (13) . Based on the results of this study, the attachment of SUMO-1 gg to RanGAP1 c does not alter the structure or dynamics of either protein beyond the site of the isopeptide linkage. Thus, RanBP2 may cooperatively recognize determinants from both SUMO-1 and RanGAP1 when the two are topologically linked through a bipartite interface. The newly formed isopeptide group could also contribute to this interaction. Given that sumoylation consensus sites appear in general to fall within flexible or unstructured polypeptide segments, we speculate that this beads-on-a-string behavior may be a common feature of the diverse regulatory processes involving sumoylated proteins, as well as proteins post-translationally modified with other Ubls. The conformational flexibility that we observed in this study may translate into plasticity important for the binding of SUMO-modified targets by their downstream effector machineries. These dynamic properties may also allow a particular SUMO-modified protein to interact specifically with different binding partners.
